SecFilingDex

ELITE PHARMACEUTICALS INC /NV/

44 SEC EDGAR filings indexed (CIK 0001053369) across 11 form types.

Filing profile

ELITE PHARMACEUTICALS INC /NV/ (ELTP) has 44 SEC filings indexed on SecFilingDex, across 11 form types filed over roughly 6 years, from May 11, 2020 to August 13, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).

Its most frequent disclosure is the 10-Q (Quarterly report) with 8 filings — Unaudited quarterly financial report filed by U.S. public companies for the first three fiscal quarters. 18 of these filings were disclosed in the twelve months to August 13, 2026. 7 of the 44 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 810-QQuarterly report · quarterly
  • 88-KMaterial event · event-driven
  • 8Form 4Insider transaction · within 2 business days of transaction
  • 710-KAnnual report · annual
  • 4Form 3Initial insider ownership · within 10 days of becoming an insider
  • 38-K/AMaterial event · event-driven
  • 210-K/AAnnual report · annual
  • 1Form 4/AInsider transaction · within 2 business days of transaction
  • 1SC 13D/A5%+ activist stake · event-driven (within 10 days)
  • 1424B3Updated prospectus · event-driven
  • 1DEFA14ASEC filing

Profile derived from 44 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1053369&type=&dateb=&owner=include&count=40 ↗

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.